These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9459455)
1. From the Food and Drug Administration. Nightingale SL JAMA; 1998 Feb; 279(5):346. PubMed ID: 9459455 [No Abstract] [Full Text] [Related]
2. Mibefradil--a new calcium-channel blocker. Med Lett Drugs Ther; 1997 Nov; 39(1013):103-5. PubMed ID: 9391500 [No Abstract] [Full Text] [Related]
3. Reports prompt new warnings on LMW heparins, heparinoids. Am J Health Syst Pharm; 1998 Feb; 55(3):210. PubMed ID: 9492250 [No Abstract] [Full Text] [Related]
4. What lessons can be learnt from withdrawal of mibefradil from the market? Po AL; Zhang WY Lancet; 1998 Jun; 351(9119):1829-30. PubMed ID: 9652662 [No Abstract] [Full Text] [Related]
5. Mibefradil and an effective formulary system. Vermeulen LC; Dunham DB Am J Health Syst Pharm; 1998 Sep; 55(18):1934-5. PubMed ID: 9784776 [No Abstract] [Full Text] [Related]
6. Spinal subarachnoid hematoma after lumbar puncture and heparinization: a case report, review of the literature, and discussion of anesthetic implications. Owens EL; Kasten GW; Hessel EA Anesth Analg; 1986 Nov; 65(11):1201-7. PubMed ID: 3767019 [No Abstract] [Full Text] [Related]
7. The withdrawal of mibefradil (Posicor). Griffin JP Adverse Drug React Toxicol Rev; 1998; 17(2-3):59-60. PubMed ID: 9838964 [No Abstract] [Full Text] [Related]
8. Comment: mibefradil, a new class of calcium-channel antagonists. Otterman S Ann Pharmacother; 1998 Dec; 32(12):1372. PubMed ID: 9876826 [No Abstract] [Full Text] [Related]
9. Rhabdomyolysis due to interaction of simvastatin with mibefradil. Schmassmann-Suhijar D; Bullingham R; Gasser R; Schmutz J; Haefeli WE Lancet; 1998 Jun; 351(9120):1929-30. PubMed ID: 9654265 [No Abstract] [Full Text] [Related]
10. Mibefradil withdrawn from the market. Billups SJ; Carter BL Ann Pharmacother; 1998; 32(7-8):841. PubMed ID: 9681103 [No Abstract] [Full Text] [Related]
11. Roche, FDA announce new drug-interaction warnings for mibefradil. Am J Health Syst Pharm; 1998 Feb; 55(3):210. PubMed ID: 9492249 [No Abstract] [Full Text] [Related]
12. Hazards of subdural and epidural anesthesia during anticoagulant therapy: a case report and review. DeAngelis J Anesth Analg; 1972; 51(5):676-9. PubMed ID: 4672158 [No Abstract] [Full Text] [Related]
13. When you suspect epidural hematoma. Stillwell SB Am J Nurs; 2000 Sep; 100(9):68-70, 72, 74 passim. PubMed ID: 11002797 [No Abstract] [Full Text] [Related]
14. Editorial on LMWH and regional anaesthesia--dangerous recommendations. Ljungström KG Acta Anaesthesiol Scand; 1999 Jan; 43(1):116-8. PubMed ID: 9926204 [No Abstract] [Full Text] [Related]
15. Subacute spinal subarachnoid hematoma following combined spinal-epidural anesthesia treated conservatively: a case report. Luo F; Cai XJ; Li ZY J Clin Anesth; 2012 Sep; 24(6):519-20. PubMed ID: 22986330 [No Abstract] [Full Text] [Related]
16. [Induction of bradycardia by mibefradil in antihypertensive combination therapy]. Wagner J; Ritz E Dtsch Med Wochenschr; 1998 Apr; 123(17):547. PubMed ID: 9601479 [No Abstract] [Full Text] [Related]
17. FDA public health advisory: low molecular-weight heparin and spinal/epidural anesthesia or spinal puncture. Lumpkin MM Int J Trauma Nurs; 1998; 4(2):56-7. PubMed ID: 9855967 [No Abstract] [Full Text] [Related]
19. Mibefradil (Posicor) induced sinus arrest. Sanders P; Walker J; Craig RJ; Hii JT; Steele PM Aust N Z J Med; 1998 Dec; 28(6):836-7. PubMed ID: 9972419 [No Abstract] [Full Text] [Related]
20. Spinal/epidural haematomas associated with neuraxial anaesthesia in the presence of heparin and low-molecular-weight heparins. Payne K; Mehta U S Afr Med J; 2000 Jun; 90(6):604. PubMed ID: 10918889 [No Abstract] [Full Text] [Related] [Next] [New Search]